Finance
Kane Biotech Secures $250,000 Insider Loan for Working Capital
Kane Biotech Inc. has accepted a $250,000 unsecured, non-interest-bearing loan from its Board Chair, Philip Renaud, to bolster working capital.
#biotech 3 articles
Stocks
Sanofi’s Lunsekimig Achieves Phase 2 Endpoints in Asthma, CRSwNP Studies
Sanofi's novel bispecific Nanobody VHH, lunsekimig, met primary and key secondary endpoints in its Phase 2 trials for asthma and CRSwNP, the...
Stocks
Neurocrine Nears $2.5B-Plus Soleno Acquisition
Neurocrine Biosciences is in advanced talks to acquire Soleno Therapeutics for over $2.5 billion, potentially valuing Soleno shares in the low-to-mid $50s,...